Search Results 921-930 of 19988 for Hepatitis C

  1. Deuruxolitinib (oral route) - Side effects & dosage - Mayo Clinic

    Hepatitis C, history of or; Herpes zoster infection or; Kidney disease or; Liver disease or; Lung or breathing problems or; Stomach or bowel problems (eg, ...

  2. Julio C. Mendez, M.D. - Doctors and Medical Staff - Mayo Clinic

    Julio C. Mendez, M.D.. Infectious Disease Specialist; Internist. Request an ... FacultyMayo 3-site Hepatitis/HIV working group. 2003 - 2009. MemberDuval ...

  3. Abdominal pain Causes - Mayo Clinic

    Hepatitis A · Hepatitis B · Hepatitis B and Hepatitis C: What's the difference? Hepatocellular carcinoma (HCC) · Hives and angioedema · How irritable bowel ...

  4. Mayo Clinic announces 2019 Distinguished Alumni Awards

    Wolpert is recognized as an international leader in medicine, an expert in the treatment and management of hepatitis C, and a force in public health. He has ...

  5. Phase I Study Of BL0020, A Novel Anti-tumor Drug, In Adult Subjects With Advanced Solid Tumors - Mayo Clinic

    Patients with active hepatitis C or chronic hepatitis B at screening ("active hepatitis" defined as HCV RNA level ≥ 200 IU/mL for hepatitis C or HBV DNA ...

  6. Publications - Basar Sareyyupoglu, M.D. - Mayo Clinic

    Effect of Hepatitis C Positivity on Survival in Adult Patients Undergoing ... Erdogan HB, Erentug V, Sareyyupoglu B, Sonmez K, Guzelmeric F, Kirali K, Kaymaz C, ...

  7. Center for Cell Signaling in Gastroenterology (C-SiG)

    The Center for Cell Signaling in Gastroenterology (C-SiG) at Mayo Clinic studies the signaling pathways in gastrointestinal cells to treat GI diseases.

  8. A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03) - Mayo Clinic

    Has active or uncontrolled hepatitis B or C infection; subject is positive for hepatitis B or C virus (HBV and HCV, respectively) based on the evaluation of ...

  9. Efineptakin alfa (NT-I7) Plus Pembrolizumab for the Treatment of Recurrent Glioblastoma - Mayo Clinic

    ... Hepatitis B and Hepatitis C is required unless mandated by local health authority * NOTE: Patients with known Hepatitis B OR Hepatitis C may be enrolled ...

  10. Publications - Dave R. Patel, M.D. - Mayo Clinic

    Scleritis associated with hepatitis C: a case report and review of literature. Ann Ophthalmol (Skokie). 2008 Fall-Winter; 40(3-4):197-9. View PubMed; Kelley ...